News | December 13, 2021
Venky’s sets up plant to manufacture veterinary medicinal products
The total cost of the project is estimated at Rs 30 crore
The total cost of the project is estimated at Rs 30 crore
The platform’s technology works as a compression algorithm for molecular testing
The fund aims at investing in companies that extends human healthspan
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The consideration for the acquisition is US $ 2.25 million
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
Subscribe To Our Newsletter & Stay Updated
